HK Stock MarketDetailed Quotes

01177 SINO BIOPHARM

Watchlist
  • 3.350
  • +0.060+1.82%
Not Open Dec 3 16:08 CST
62.95BMarket Cap14.02P/E (TTM)

SINO BIOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(Q3)Mar 31, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
Turnover
11.14%15.87B
0.67%26.2B
-5.99%14.28B
-3.11%26.03B
5.85%15.19B
13.59%26.86B
13.49%14.35B
16.41%7.24B
-2.42%23.65B
-6.18%18.13B
Operating income
11.14%15.87B
0.67%26.2B
-5.99%14.28B
-3.11%26.03B
5.85%15.19B
13.59%26.86B
13.49%14.35B
16.41%7.24B
-2.42%23.65B
-6.18%18.13B
Cost of sales
-9.42%-2.84B
-11.19%-4.99B
12.16%-2.6B
15.84%-4.49B
-7.50%-2.96B
-2.89%-5.33B
1.39%-2.75B
-11.75%-1.42B
-5.20%-5.18B
-8.05%-4.07B
Operating expenses
-9.42%-2.84B
-11.19%-4.99B
12.16%-2.6B
15.84%-4.49B
-7.50%-2.96B
-2.89%-5.33B
1.39%-2.75B
-11.75%-1.42B
-5.20%-5.18B
-8.05%-4.07B
Gross profit
11.52%13.03B
-1.53%21.21B
-4.50%11.68B
0.04%21.54B
5.46%12.23B
16.60%21.53B
17.70%11.6B
17.60%5.83B
-4.37%18.46B
-9.64%14.05B
Selling expenses
-11.03%-5.8B
6.28%-9.19B
9.23%-5.22B
6.74%-9.81B
-1.52%-5.75B
-17.23%-10.52B
-22.83%-5.67B
-22.58%-3.05B
3.72%-8.97B
9.65%-6.86B
Administrative expenses
-4.58%-1.05B
1.38%-1.87B
14.99%-1.01B
13.08%-1.9B
-4.97%-1.18B
17.72%-2.19B
-6.90%-1.13B
-1.69%-448.06M
-2.58%-2.66B
-4.58%-1.79B
Operating interest expense
----
----
----
----
-14.98%-169.27M
4.56%-308.62M
15.55%-147.22M
20.76%-71.66M
---323.37M
----
Special items of operating profit
-22.74%-2.32B
7.95%-3.71B
-0.61%-1.89B
-12.79%-4.03B
-48.22%-1.88B
-138.87%-3.58B
7.01%-1.27B
-38.40%-889.49M
11.78%-1.5B
20.02%-1.3B
Operating profit
8.24%3.86B
10.93%6.43B
9.70%3.57B
17.31%5.8B
-4.19%3.25B
-1.48%4.94B
27.98%3.39B
5.76%1.36B
-12.03%5.02B
-11.24%4.09B
Financing cost
47.61%-153.74M
-15.31%-495.24M
---293.43M
---429.49M
----
----
----
----
----
-99.15%-265.46M
Share of profits of associates
57.59%-93.06M
-243.66%-525.71M
-143.61%-219.44M
-101.12%-152.98M
-93.37%503.16M
421,714.29%13.63B
18,515.51%7.58B
59,124.43%1.48B
-102.90%-3.23M
-1,230.97%-86.72M
Earning before tax
18.33%3.61B
3.74%5.41B
-18.66%3.05B
-71.92%5.21B
-65.80%3.75B
270.49%18.57B
320.56%10.98B
119.74%2.84B
-10.22%5.01B
-16.60%3.74B
Tax
-23.31%-614.09M
-14.43%-797.27M
12.85%-497.99M
64.41%-696.72M
57.26%-571.39M
-191.19%-1.96B
-144.71%-1.34B
-106.47%-446.94M
24.41%-672.38M
6.56%-777.69M
After-tax profit from continuing operations
17.36%3B
2.09%4.61B
-19.70%2.56B
-72.81%4.52B
-66.98%3.18B
282.77%16.61B
367.10%9.64B
122.41%2.39B
-7.53%4.34B
-18.89%2.96B
After-tax profit from non-continuing business
1,021.31%1.61B
0.06%484.76M
--143.29M
--484.47M
----
----
----
----
----
----
Earning after tax
70.65%4.61B
1.89%5.1B
-15.20%2.7B
-69.89%5B
-66.98%3.18B
282.77%16.61B
367.10%9.64B
122.41%2.39B
-7.53%4.34B
-18.89%2.96B
Minority profit
10.33%1.59B
12.46%2.77B
14.14%1.44B
22.56%2.46B
8.69%1.26B
27.83%2.01B
41.01%1.16B
139.53%480.92M
-21.03%1.57B
-20.41%1.11B
Profit attributable to shareholders
139.69%3.02B
-8.32%2.33B
-34.47%1.26B
-82.59%2.54B
-77.35%1.92B
427.17%14.61B
583.56%8.48B
118.49%1.91B
2.38%2.77B
-17.96%1.85B
Basic earnings per share
141.74%0.1639
-7.83%0.1259
-34.17%0.0678
-82.45%0.1366
-77.19%0.103
428.02%0.7783
584.09%0.4515
118.67%0.1019
-31.70%0.1474
-17.91%0.0981
Diluted earnings per share
141.74%0.1639
3.62%0.1259
-26.30%0.0678
-83.42%0.1215
-78.79%0.092
397.01%0.7326
557.27%0.4338
151.49%0.0928
-31.70%0.1474
-17.91%0.0981
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
Unqualified Opinion
--
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
--
Ernst & Young
--
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(Q3)Mar 31, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020
Turnover 11.14%15.87B0.67%26.2B-5.99%14.28B-3.11%26.03B5.85%15.19B13.59%26.86B13.49%14.35B16.41%7.24B-2.42%23.65B-6.18%18.13B
Operating income 11.14%15.87B0.67%26.2B-5.99%14.28B-3.11%26.03B5.85%15.19B13.59%26.86B13.49%14.35B16.41%7.24B-2.42%23.65B-6.18%18.13B
Cost of sales -9.42%-2.84B-11.19%-4.99B12.16%-2.6B15.84%-4.49B-7.50%-2.96B-2.89%-5.33B1.39%-2.75B-11.75%-1.42B-5.20%-5.18B-8.05%-4.07B
Operating expenses -9.42%-2.84B-11.19%-4.99B12.16%-2.6B15.84%-4.49B-7.50%-2.96B-2.89%-5.33B1.39%-2.75B-11.75%-1.42B-5.20%-5.18B-8.05%-4.07B
Gross profit 11.52%13.03B-1.53%21.21B-4.50%11.68B0.04%21.54B5.46%12.23B16.60%21.53B17.70%11.6B17.60%5.83B-4.37%18.46B-9.64%14.05B
Selling expenses -11.03%-5.8B6.28%-9.19B9.23%-5.22B6.74%-9.81B-1.52%-5.75B-17.23%-10.52B-22.83%-5.67B-22.58%-3.05B3.72%-8.97B9.65%-6.86B
Administrative expenses -4.58%-1.05B1.38%-1.87B14.99%-1.01B13.08%-1.9B-4.97%-1.18B17.72%-2.19B-6.90%-1.13B-1.69%-448.06M-2.58%-2.66B-4.58%-1.79B
Operating interest expense -----------------14.98%-169.27M4.56%-308.62M15.55%-147.22M20.76%-71.66M---323.37M----
Special items of operating profit -22.74%-2.32B7.95%-3.71B-0.61%-1.89B-12.79%-4.03B-48.22%-1.88B-138.87%-3.58B7.01%-1.27B-38.40%-889.49M11.78%-1.5B20.02%-1.3B
Operating profit 8.24%3.86B10.93%6.43B9.70%3.57B17.31%5.8B-4.19%3.25B-1.48%4.94B27.98%3.39B5.76%1.36B-12.03%5.02B-11.24%4.09B
Financing cost 47.61%-153.74M-15.31%-495.24M---293.43M---429.49M---------------------99.15%-265.46M
Share of profits of associates 57.59%-93.06M-243.66%-525.71M-143.61%-219.44M-101.12%-152.98M-93.37%503.16M421,714.29%13.63B18,515.51%7.58B59,124.43%1.48B-102.90%-3.23M-1,230.97%-86.72M
Earning before tax 18.33%3.61B3.74%5.41B-18.66%3.05B-71.92%5.21B-65.80%3.75B270.49%18.57B320.56%10.98B119.74%2.84B-10.22%5.01B-16.60%3.74B
Tax -23.31%-614.09M-14.43%-797.27M12.85%-497.99M64.41%-696.72M57.26%-571.39M-191.19%-1.96B-144.71%-1.34B-106.47%-446.94M24.41%-672.38M6.56%-777.69M
After-tax profit from continuing operations 17.36%3B2.09%4.61B-19.70%2.56B-72.81%4.52B-66.98%3.18B282.77%16.61B367.10%9.64B122.41%2.39B-7.53%4.34B-18.89%2.96B
After-tax profit from non-continuing business 1,021.31%1.61B0.06%484.76M--143.29M--484.47M------------------------
Earning after tax 70.65%4.61B1.89%5.1B-15.20%2.7B-69.89%5B-66.98%3.18B282.77%16.61B367.10%9.64B122.41%2.39B-7.53%4.34B-18.89%2.96B
Minority profit 10.33%1.59B12.46%2.77B14.14%1.44B22.56%2.46B8.69%1.26B27.83%2.01B41.01%1.16B139.53%480.92M-21.03%1.57B-20.41%1.11B
Profit attributable to shareholders 139.69%3.02B-8.32%2.33B-34.47%1.26B-82.59%2.54B-77.35%1.92B427.17%14.61B583.56%8.48B118.49%1.91B2.38%2.77B-17.96%1.85B
Basic earnings per share 141.74%0.1639-7.83%0.1259-34.17%0.0678-82.45%0.1366-77.19%0.103428.02%0.7783584.09%0.4515118.67%0.1019-31.70%0.1474-17.91%0.0981
Diluted earnings per share 141.74%0.16393.62%0.1259-26.30%0.0678-83.42%0.1215-78.79%0.092397.01%0.7326557.27%0.4338151.49%0.0928-31.70%0.1474-17.91%0.0981
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion----Unqualified Opinion--
Auditor --Ernst & Young--Ernst & Young--Ernst & Young----Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data